Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Rectal Neoplasms 1Pain, Postoperative 1Ileus 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colonic Neoplasms 1Agnosia 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Orphenadrine × Gastrointestinal × Clear all
NCT02958566 2017-03-20

Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery

University of Illinois College of Medicine at Peoria

Phase 4 Unknown
80 enrolled
GastrointestinalOther

Agnosia, Colonic Neoplasms, Constipation, Diverticulitis, Colonic, Pain, Postoperative, Rectal Neoplasms, Diverticulosis, Colonic, Ileus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡